Evidence map›Paper›PMID 14586476›Full record

ArticleLeukemia2004

Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow.

M Z Ratajczak, M Kucia, R Reca, M Majka, A Janowska-Wieczorek, J Ratajczak

Open access · greenAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Leukemia, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 327 citations in OpenAlex.

  1. Trial
  2. CD31Physiological reports · 2026
    Article
  3. Anti-myeloma activity of the CXCR4 antagonist WZ811.Journal of molecular medicine (Berlin, Germany) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Systemic Injection of RPE65-Programmed Bone Marrow-Derived Cells Prevents Progression of Chronic Retinal Degeneration.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Intestinal stem cells and celiac disease.World journal of stem cells · 2014
    Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

M Z RatajczakStem Cell Biology Program at James Graham Brown Cancer Center and Department of Medicine, University of Louisville, Louisville, KY 40202, USA.
M Kucia
R Reca
M Majka
A Janowska-Wieczorek
J Ratajczak
Jagiellonian University · PLUniversity of Louisville · USUniversity of Alberta · CA

Funding

CELLULAR AND MOLECULAR BASIS OF HIV BASED THROMBOCYTOPENR01HL061796 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RATAJCZAK, MARIUSZ Z · 1998 to 2002
$926k
NHLBI NIH HHS R01 HL61796-01
6 · The paper itself

Abstract

It has been suggested that bone marrow (BM)-derived hematopoietic stem cells transdifferentiate into tissue-specific stem cells (the so-called phenomenon of stem cell plasticity), but the possibility of committed tissue-specific stem cells pre-existing in BM has not been given sufficient consideration. We hypothesized that (i) tissue-committed stem cells circulate at a low level in the peripheral blood (PB) under normal steady-state conditions, maintaining a pool of stem cells in peripheral tissues, and their levels increase in PB during stress/tissue injury, and (ii) they could be chemoattracted to the BM where they find a supportive environment and that the SDF-1-CXCR4 axis plays a prominent role in the homing/retention of these cells to BM niches. We performed all experiments using freshly isolated cells to exclude the potential for 'transdifferentiation' of hematopoietic stem or mesenchymal cells associated with in vitro culture systems. We detected mRNA for various early markers for muscle (Myf-5, Myo-D), neural (GFAP, nestin) and liver (CK19, fetoprotein) cells in circulating (adherent cell-depleted) PB mononuclear cells (MNC) and increased levels of expression of these markers in PB after mobilization by G-CSF (as measured using real-time RT-PCR). Furthermore, SDF-1 chemotaxis combined with real-time RT-PCR analysis revealed that (i) these early tissue-specific cells reside in normal murine BM, (ii) express CXCR4 on their surface and (iii) can be enriched (up to 60 x) after chemotaxis to an SDF-1 gradient. These cells were also highly enriched within purified populations of murine Sca-1(+) BM MNC as well as of human CD34(+)-, AC133(+)- and CXCR4-positive cells. We also found that the expression of mRNA for SDF-1 is upregulated in damaged heart, kidney and liver. Hence our data provide a new perspective on BM not only as a home for hematopoietic stem cells but also a 'hideout' for already differentiated CXCR4-positive tissue-committed stem/progenitor cells that follow an SDF-1 gradient, could be mobilized into PB, and subsequently take part in organ/tissue regeneration.

Indexed as

DNA-Binding ProteinsNerve Tissue ProteinsTrans-Activatorsalpha-FetoproteinsAnimalsAntigens, CD34BiomarkersBlood CellsBone MarrowCell LineChemokine CXCL12Chemokines, CXCFemaleGlial Fibrillary Acidic ProteinGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell Mobilizationalpha-FetoproteinsAntigens, CD34BiomarkersChemokine CXCL12Chemokines, CXCCXCL12 protein, humanCxcl12 protein, mouseDNA-Binding ProteinsGlial Fibrillary Acidic ProteinGranulocyte Colony-Stimulating FactorIntermediate Filament ProteinsKeratinsMuscle ProteinsMYF5 protein, humanMyf5 protein, mouseMyoD ProteinMyogenic Regulatory Factor 5Nerve Tissue ProteinsNES protein, humanNes protein, mouseNestinReceptors, CXCR4RNA, MessengerTrans-Activators

Identifiers

PMID14586476
OpenAlexW1969986792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.